Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Current Taxes: 2017-2018

Historic Current Taxes for Corcept Therapeutics (CORT) over the last 1 years, with Sep 2018 value amounting to $1.6 million.

  • Corcept Therapeutics' Current Taxes was N/A to $1.6 million in Q3 2018 from the same period last year, while for Sep 2018 it was $1.6 million, marking a year-over-year change of. This contributed to the annual value of $66,000 for FY2017, which is N/A change from last year.
  • Per Corcept Therapeutics' latest filing, its Current Taxes stood at $1.6 million for Q3 2018, which was up 130.42% from $687,000 recorded in Q2 2018.
  • In the past 5 years, Corcept Therapeutics' Current Taxes registered a high of $1.6 million during Q3 2018, and its lowest value of $66,000 during Q4 2017.
  • In the last 2 years, Corcept Therapeutics' Current Taxes had a median value of $707,500 in 2018 and averaged $766,000.